End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.02 EGP | -4.36% | -15.83% | -48.19% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-48.19% | 182M | - | - | |
-0.19% | 74.89B | B | ||
+0.09% | 46.52B | A- | ||
-4.19% | 30.82B | C | ||
+9.85% | 18.19B | B | ||
-10.05% | 11.54B | B | ||
+6.39% | 11.24B | A- | ||
-8.09% | 9.73B | - | ||
+2.79% | 9.4B | A- | ||
+6.35% | 9.37B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EGCH Stock
- Ratings Egyptian Chemical Industries